Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2013 (2013), Article ID 349512, 7 pages
http://dx.doi.org/10.1155/2013/349512
Clinical Study

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients

1Intensive Care Unit, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
2Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong

Received 29 September 2012; Revised 1 December 2012; Accepted 19 December 2012

Academic Editor: Manuel E. Herrera-Gutiérrez

Copyright © 2013 Anne Kit-Hung Leung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Mehta, B. R. McDonald, M. M. Aguilar, and D. M. Ward, “Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients,” Kidney International, vol. 38, no. 5, pp. 976–981, 1990. View at Google Scholar · View at Scopus
  2. R. Palsson and J. L. Niles, “Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding,” Kidney International, vol. 55, no. 5, pp. 1991–1997, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Kutsogiannis, I. Mayers, W. D. N. Chin, and R. T. N. Gibney, “Regional citrate anticoagulation in continuous venovenous hemodiafiltration,” American Journal of Kidney Diseases, vol. 35, no. 5, pp. 802–811, 2000. View at Google Scholar · View at Scopus
  4. A. J. Tolwani, R. C. Campbell, M. B. Schenk, M. Allon, and D. G. Warnock, “Simplified citrate anticoagulation for continuous renal replacement therapy,” Kidney International, vol. 60, no. 1, pp. 370–374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Bihorac and E. A. Ross, “Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition,” American Journal of Kidney Diseases, vol. 46, no. 5, pp. 908–918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Kutsogiannis, R. T. N. Gibney, D. Stollery, and J. Gao, “Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients,” Kidney International, vol. 67, no. 6, pp. 2361–2367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Tolwani, M. B. Prendergast, R. R. Speer, B. S. Stofan, and K. M. Wille, “A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 1, pp. 79–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. W. Tobe, P. Aujla, A. A. Walele et al., “A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions,” Journal of Critical Care, vol. 18, no. 2, pp. 121–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Cointault, N. Kamar, P. Bories et al., “Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions,” Nephrology Dialysis Transplantation, vol. 19, no. 1, pp. 171–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. K. H. Leung and W. W. Yan, “Renal replacement therapy in critically ill patients,” Hong Kong Medical Journal, vol. 15, no. 2, pp. 122–129, 2009. View at Google Scholar · View at Scopus
  11. M. Egi, T. Naka, R. Bellomo et al., “A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration,” International Journal of Artificial Organs, vol. 28, no. 12, pp. 1211–1218, 2005. View at Google Scholar · View at Scopus
  12. M. Schmitz, G. Taskaya, J. Plum et al., “Continuous venovenous haemofiltration using a citrate buffered substitution fluid,” Anaesthesia and Intensive Care, vol. 35, no. 4, pp. 529–535, 2007. View at Google Scholar · View at Scopus
  13. S. Morgera, M. Schneider, T. Slowinski et al., “A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status,” Critical Care Medicine, vol. 37, no. 6, pp. 2018–2024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. P. Shum, K. C. Chan, and W. W. Yan, “Regional citrate anti-coagulation in predilution continuous venovenous hemofiltration using Prismocitrate 10/2 solution,” Therapeutic Apheresis and Dialysis, vol. 16, no. 1, pp. 81–86, 2012. View at Google Scholar
  15. E. Ooi, T. Lim, and N. Lim, “Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous hemodiafiltration,” Critical Care, vol. 14, Supplement 11, p. S515, 2010. View at Google Scholar
  16. M. Brain, S. Parkes, P. Fowler, I. Robertson, and A. Brown, “Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation,” Critical Care and Resuscitation, vol. 13, no. 2, pp. 72–81, 2011. View at Google Scholar · View at Scopus
  17. M. J. Flanigan, L. Pillsbury, G. Sadewasser, and V. S. Lim, “Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A,” American Journal of Kidney Diseases, vol. 27, no. 4, pp. 519–524, 1996. View at Google Scholar · View at Scopus
  18. C. Ronco, R. Bellomo, P. Homel et al., “Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial,” The Lancet, vol. 356, no. 9223, pp. 26–30, 2000. View at Google Scholar · View at Scopus
  19. P. M. Palevsky, J. H. Zhang, T. Z. O'Connor et al., “Intensity of renal support in critically ill patients with acute kidney injury,” The New England Journal of Medicine, vol. 359, no. 1, pp. 7–20, 2008. View at Google Scholar
  20. R. Bellomo, A. Cass, L. Cole et al., “Intensity of continuous renal-replacement therapy in critically ill patients,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1627–1638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. M. O. Straaten, R. J. Bosman, M. Koopmans et al., “Citrate anticoagulation for continuous venovenous hemofiltration,” Critical Care Medicine, vol. 37, no. 2, pp. 545–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. U. Meier-Kriesche, J. Gitomer, K. Finkel, and T. DuBose, “Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation,” Critical Care Medicine, vol. 29, no. 4, pp. 748–752, 2001. View at Google Scholar · View at Scopus
  23. C. Schultheiss, B. Saugel, and V. Phillip, “Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study,” Critical Care, vol. 16, no. 4, article R162, 2012. View at Google Scholar